Mon, Jan 26, 2015, 1:46 AM EST - U.S. Markets open in 7 hrs 44 mins


% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • b_leaguered b_leaguered Jun 29, 2013 7:57 PM Flag

    Some differences from the CLSN experience

    In the days leading up to the CLSN massacre on 1/31/13, there were some serious hit pieces written by Adam Feuerstein of thestreetdotcom. The company's market cap was below $300 million which predicted failure for pIII oncology trials according to the Feuerstein-Ratian rule. We haven't seen any high profile hit pieces on INSM. The Motley Fool article seemed to be a fluff piece written by someone that knew little about INSM. Also, several weeks before pIII data, in a bold move, one investment bank (Aschoff at Brean Murray) covering CLSN lowered its price target from $7 to $1. We haven't seen any defections from the analysts covering INSM. They have been raising price targets, not lowering them. The only INSM detractors are on this a supposed surf dude, and the other, a KGB agent.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
14.89+0.3000(+2.06%)Jan 23 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.